Our study was performed to address first the expression of VEGF and MVD in malignant epithelial thyroid cancers, i.e. papillary (PTC), folicular (FTC) and anaplastic (ATC). The gene discussed is VEGFA; the disease is thyroid cancer, nonmedullary, 2.